YOLFTbeta
30

Inner Mongolia Furui Med Sci

300049 · SHE · Healthcare / Biotechnology

43.43CNY-0.92 (-2.07%)

Price History

Full chart

Market Stats

Previous Close44.35
Open44.00
Day Range42.90 – 44.78
52-Week Range36.37 – 86.60
Volume8.82M
Market Cap12.44B
P/E (TTM)75.98
Forward P/E200.00
EPS0.62
Dividend Yield0.32%
Beta-0.29
50-Day Avg44.46
200-Day Avg54.11

About

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liver disease; and FibroView data management software. It provides digital health management services; compound turtle shell softening liver tablets; and prescription drugs. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Guanyi Wang
  • Employees946
  • HeadquartersCentral Tower, Zhonghai Plaza, Beijing, China, 100020, China
  • Websitehttps://www.fu-rui.com

Leadership

  • Mr. Guanyi WangGM & Chairman · b. 1970
  • Mr. Zhi Guo ShenDeputy GM & CFO · b. 1977
  • Ms. Lijuan DengDeputy GM & Director · b. 1964
  • Ms. Xiu Zhen SunBoard Secretary · b. 1971
  • Ms. Li Qun WangDeputy General Manager · b. 1968

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue121.59M126.41M141.26M179.98M210.25M301.66M407.64M523.48M645.52M604.19M826.99M823.33M867.03M831.74M807.53M898.48M1.01B1.15B1.35B1.59B
Growth (%)-+3.97%+11.74%+27.41%+16.82%+43.48%+35.13%+28.42%+23.31%-6.40%+36.88%-0.44%+5.31%-4.07%-2.91%+11.26%+12.27%+14.37%+16.93%+18.07%
Cost of Revenue36.28M37.45M46.03M48.11M60.71M85.79M125.91M240.69M231.77M197.16M230.86M216.93M260.97M239.06M226.65M239.14M267.67M291.39M350.73M504.19M
Gross Profit85.31M88.96M95.23M131.86M149.53M215.87M281.72M282.80M413.75M407.04M596.12M606.40M606.06M592.68M580.88M659.34M741.09M862.34M998.28M1.09B
Gross Margin70.16%70.37%67.42%73.27%71.12%71.56%69.11%54.02%64.10%67.37%72.08%73.65%69.90%71.26%71.93%73.38%73.47%74.74%74.00%68.35%
Operating Expense59.33M62.36M57.60M82.40M85.29M146.24M230.95M265.24M287.77M286.00M410.47M467.22M482.76M465.54M461.16M470.59M548.42M609.21M720.39M688.95M
Operating Income25.98M26.60M37.63M49.46M64.24M69.63M50.78M17.56M125.98M121.03M185.65M139.18M123.30M127.14M119.72M188.75M192.67M253.13M277.89M399.70M
Operating Margin21.37%21.04%26.64%27.48%30.55%23.08%12.46%3.35%19.52%20.03%22.45%16.90%14.22%15.29%14.83%21.01%19.10%21.94%20.60%25.09%
EBITDA34.11M36.44M40.85M54.51M71.67M79.82M61.78M33.66M165.79M138.95M210.77M195.91M164.90M193.45M209.72M221.12M236.39M307.52M358.88M504.52M
EBITDA Margin28.06%28.83%28.92%30.29%34.09%26.46%15.15%6.43%25.68%23.00%25.49%23.80%19.02%23.26%25.97%24.61%23.43%26.65%26.60%31.67%
Net Income22.61M22.48M25.82M34.42M46.85M52.49M41.14M4.91M87.24M91.69M121.05M61.11M35.42M43.39M61.91M95.47M97.89M101.56M113.29M154.09M
Net Income Margin18.59%17.78%18.28%19.12%22.28%17.40%10.09%0.94%13.51%15.17%14.64%7.42%4.08%5.22%7.67%10.63%9.70%8.80%8.40%9.67%
R&D----1.57M6.13M20.88M36.88M26.43M45.40M46.87M60.31M64.73M60.75M65.82M64.79M70.82M82.47M105.07M77.03M
R&D as % of Total Revenue----0.75%2.03%5.12%7.04%4.09%7.51%5.67%7.32%7.47%7.30%8.15%7.21%7.02%7.15%7.79%4.84%
Interest Expense2.06M2.81M4.01M3.72M2.01M2.66M2.12M3.13M5.65M3.16M2.81M3.32M5.01M3.66M3.21M2.58M1.82M1.42M2.98M3.55M
Interest Expense % of Total Revenue1.70%2.22%2.84%2.07%0.95%0.88%0.52%0.60%0.88%0.52%0.34%0.40%0.58%0.44%0.40%0.29%0.18%0.12%0.22%0.22%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets187.80M200.93M223.10M250.96M795.66M873.44M927.58M1.14B1.33B2.04B2.41B2.51B2.14B2.25B2.29B2.52B2.52B2.65B3.06B3.44B
Total Liabilities63.29M73.17M83.58M93.51M108.24M170.37M193.94M393.25M416.10M390.37M581.15M594.42M622.47M698.66M675.02M718.97M697.25M800.09M930.99M652.21M
Total Equity124.15M127.44M139.51M157.43M687.42M703.08M707.96M713.86M835.01M1.34B1.46B1.50B1.33B1.32B1.35B1.52B1.55B1.55B1.75B1.98B
Cash32.12M33.37M48.59M22.51M500.48M363.80M381.49M325.81M344.08M907.85M760.02M619.01M202.23M299.08M467.90M472.72M479.21M509.59M566.83M649.74M
Total Debt31.65M46.65M44.50M56.35M51.20M77.61M69.36M95.82M90.45M100.54M70.15M85.00M78.50M108.67M115.23M94.13M42.99M44.90M55.24M137.09M
Net Debt-466.16K13.28M-4.09M33.84M-449.28M-286.19M-312.13M-229.99M-253.63M-807.31M-689.87M-534.01M-123.73M-190.41M-352.67M-378.59M-436.22M-464.69M-511.59M-512.65M

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow49.52M17.85M36.47M-2.10M49.20M75.75M85.88M28.18M50.88M158.16M148.84M131.72M78.35M256.23M200.15M222.55M189.46M304.89M221.41M354.15M
Investing Cash Flow-13.13M-7.54M-4.34M-10.79M-47.51M-210.38M-20.95M-117.38M-98.80M153.40M-266.01M-294.04M-81.14M-125.12M-32.07M-182.56M-68.45M-150.43M-306.38M-214.31M
Financing Cash Flow-16.98M-9.06M-16.90M-13.19M476.29M1.23M-47.50M32.22M73.49M231.87M-53.19M-9.83M-415.42M-35.80M1.40M-6.65M-126.54M-137.14M138.52M-71.61M
Capital Expenditure13.13M7.54M4.34M11.74M38.84M39.72M24.60M237.51M83.60M127.45M213.50M39.63M93.96M66.29M109.74M79.61M90.78M189.23M218.97M189.01M
Free Cash Flow36.38M10.30M32.13M-13.84M10.36M36.03M61.28M-209.33M-32.72M30.71M-64.66M86.53M-15.62M189.93M90.41M128.70M98.69M115.66M2.44M165.14M
Dividends Paid14.13M23.62M14.48M23.46M24.21M16.40M39.64M2.89M3.27M26.35M27.77M32.35M31.13M2.97M3.76M1.95M71.41M53.42M2.20M2.29M
FCF to OCF73.48%57.74%88.09%660.11%21.06%47.57%71.35%-742.75%-64.31%19.42%-43.44%65.69%-19.93%74.13%45.17%57.83%52.09%37.94%1.10%46.63%
Dividend Paid to FCF38.83%229.19%45.08%-169.59%233.60%45.51%64.69%-1.38%-9.98%85.79%-42.94%37.39%-199.34%1.56%4.15%1.51%72.37%46.19%90.19%1.39%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013May 28, 2014Aug 26, 2014Oct 23, 2014Apr 25, 2015Aug 25, 2015Oct 25, 2015Feb 29, 2016Apr 26, 2016Aug 26, 2016Oct 28, 2016Feb 24, 2017Apr 26, 2017Aug 28, 2017Oct 29, 2017Apr 27, 2018Aug 29, 2018Oct 29, 2018Apr 25, 2019Aug 29, 2019Oct 29, 2019Apr 27, 2020Aug 27, 2020Oct 28, 2020Apr 27, 2021Aug 27, 2021Oct 28, 2021Apr 27, 2022Aug 28, 2022Oct 27, 2022Apr 26, 2023Aug 28, 2023Oct 25, 2023Apr 28, 2024Aug 29, 2024Oct 24, 2024Apr 21, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------------
EPS Actual0.040.050.040.070.040.050.050.070.040.070.06-0.010.010.010.01-0.010.020.040.100.030.110.030.180.030.140.040.260.030.120.040.040.140.040.030.040.030.040.020.060.120.110.060.030.090.110.140.120.110.160.120.100.110.090.230.160.120.12
Surprise---------------------------------------------------------
Timing-----------------Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-market-----

Key Statistics & Ratios

Market Cap12.44B
Enterprise Value12.61B
Trailing P/E75.98
Forward P/E200.00
Price / Sales7.60
Price / Book6.66
EPS0.62
Book Value7.45
Revenue (TTM)1.64B
Gross Profit (TTM)1.23B
EBITDA495.34M
Profit Margin10.15%
Operating Margin21.45%
Return on Equity12.48%
Return on Assets7.77%
Shares Outstanding263.99M
Shares Float202.76M
Beta-0.29
Dividend Yield0.32%
Dividend Rate0.15
Payout Ratio23.71%

Dividends

20261×
0.15Jul 6, 2026
20231×
0.20Jun 13, 2023
20181×
0.10Jul 2, 2018
20171×
0.10May 25, 2017
20161×
0.10Jun 23, 2016
20151×
0.10Jul 6, 2015
20121×
0.15Jul 9, 2012
20111×
0.12May 4, 2011
20101×
0.09May 12, 2010

Stock Splits

  • Jul 6, 201520:10
  • May 4, 201113:10
  • Sep 30, 201013:10